US4479793A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Parenteral administration using drug delivery device
Assignee: Alza Corp
•
Filing: 1983-10-11
•
Granted: 1984-10-30
•
Expires: 2003-10-11
Abstract
Abstract A parenteral delivery system is disclosed for administering a beneficial agent to a recipient. The system comprises (a) a container of a medical fluid; (b) a primary tubing in communication with the container; (c) a parallel tubing connected to the primary tubing having a formulation chamber connected thereto, the formulation chamber housing a beneficial agent, or a device for delivering a beneficial agent; and (d) a common tubing connected to the primary tubing and the parallel tubing for administering the fluid and the agent to a recipient.
Inventors
- 👤 John Urquhart
- 👤 Felix Theeuwes
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-01 06:25
CPC Classifications
A; A61; A61M; A61M5/00; A61M5/14; A61M5/1407; A61M5/1409; A61M5/142; A61M5/145; A61M2005/14513
Claims Analysis
Total Claims: 4
Claim 1
Independent Claim
190 words
An administration set for use with a parenteral therapeutic system, the administration set comprising: (a) a primary tube for the flow of a medical fluid therethrough; (b) a parallel tube in fluid communication with the primary tube for the flow of medical fluid therethrough; and, (c) a drug formulation chamber in the parallel tube, the chamber comprising; (1) a wall surrounding a space; (2) an inlet in the wall that communicates with the parallel tube for receiving fluid into the chamber; (3) a drug delivery device in the chamber, said device comprising a wall formed of a microporous material that substantially surrounds a solid reservoir containing a dosage unit amount of a beneficial drug that forms on its release from the device a drug formulation with fluid that enters the chamber and wherein, when the administration set is in operation and administering drug to a recipient, a beneficially effective amount of the drug is administered by the combined operations of the device releasing drug and the rate of fluid flow through the chamber; and, (4) an outlet in the wall for the flow of fluid containing drug from the chamber.
Claim 2
Dependent Claim
190 words
An administration set for use with a parenteral therapeutic system, the administration set comprising: (a) a primary tube for the flow of a medical fluid therethrough; (b) a parallel tube in fluid communication with the primary tube for the flow of medical fluid therethrough; and, (c) a drug formulation chamber in the parallel tube, the chamber comprising; (1) a wall surrounding a space; (2) an inlet in the wall that communicates with the parallel tube for receiving fluid into the chamber; (3) a drug delivery device in the chamber, said device comprising a wall formed of a microporous material that substantially surrounds a solid reservoir containing a dosage unit amount of a beneficial drug that forms on its release from the device a drug formulation with fluid that enters the chamber and wherein, when the administration set is in operation and administering drug to a recipient, a beneficially effective amount of the drug is administered by the combined operations of the device releasing drug and the rate of fluid flow through the chamber; and, (4) an outlet in the wall for the flow of fluid containing drug from the chamber.
Claim 3
Dependent Claim
187 words
An administration set for use with a parenteral therapeutic system, the administration set comprising: (a) a primary tube for the flow of a medical fluid therethrough; (b) a parallel tube in fluid communication with the primary tube for the flow of the medical fluid therethrough; and, (c) a drug formulation chamber connected to the parallel tube, the chamber comprising: (1) a wall surrounding a lumen; (2) an inlet in the wall that communicates with the parallel tube for receiving a fluid that flows into the chamber; (3) a drug delivery device in the chamber, the device comprising a matrix formed of a microporous material containing a dosage amount of a beneficial drug that forms on its release from the device a drug formulation with fluid that enters the chamber and wherein, when the administration set is in operation and administering drug to a recipient, a beneficially effective amount of the drug is administered by the combined operations of the device releasing drug and the rate of fluid flow through the chamber; and, (4) an outlet in wall for the flow of fluid containing drug from the chamber.
Claim 4
Dependent Claim
187 words
An administration set for use with a parenteral therapeutic system, the administration set comprising: (a) a primary tube for the flow of a medical fluid therethrough; (b) a parallel tube in fluid communication with the primary tube for the flow of the medical fluid therethrough; and, (c) a drug formulation chamber connected to the parallel tube, the chamber comprising: (1) a wall surrounding a lumen; (2) an inlet in the wall that communicates with the parallel tube for receiving a fluid that flows into the chamber; (3) a drug delivery device in the chamber, the device comprising a matrix formed of a microporous material containing a dosage amount of a beneficial drug that forms on its release from the device a drug formulation with fluid that enters the chamber and wherein, when the administration set is in operation and administering drug to a recipient, a beneficially effective amount of the drug is administered by the combined operations of the device releasing drug and the rate of fluid flow through the chamber; and, (4) an outlet in wall for the flow of fluid containing drug from the chamber.
References Cited (Backward Citations)
CH49781A
Cited
US1654745A
Cited
US2849256A
Cited
US3305446A
Cited
US3993073A
Cited
US3797494A
Cited
US3854480A
Cited
US3995631A
Cited
US3756237A
Cited
US3760984A
Cited
US3948254A
Cited
US3845770A
Cited
US3921636A
Cited
US4177256A
Cited
US3941126A
Cited
US3993072A
Cited
US3993066A
Cited
US4203439A
Cited
US4217894A
Cited
US4233973A
Cited
US4219022A
Cited
US4256104A
Cited
US4256105A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-10-30 | 1988-04-30 | 1988-10-30 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-10-30 | 1992-04-30 | 1992-10-30 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-10-30 | 1996-04-30 | 1996-10-30 | $7700.00 | Window Closed / Lapsed |